AI can evaluate connections from data that may appear irrelevant to a person, which could help pharmaceutical companies avoid distributing contaminated products, Marla Phillips, director of Cincinnati-based Xavier Health, told WVXU.
Ms. Phillips cited a 2008 incident in which 81 people died after being injected with contaminated heparin, an anticoagulant. Using computer systems to evaluate data sources could have predicted a problem with the drug before it was used, she added.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Samsung widens stake in prescription drug market through partnership with Japanese pharmaceutical company
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
